Display options
Cite
Kalita H, Boruah DC, Deori M, et al. Antidiabetic and Antilipidemic Effect of Musa balbisiana Root Extract: A Potent Agent for Glucose Homeostasis in Streptozotocin-Induced Diabetic Rat. Front Pharmacol. 2016;7:102doi: 10.3389/fphar.2016.00102.
Kalita, H., Boruah, D. C., Deori, M., Hazarika, A., Sarma, R., Kumari, S., Kandimalla, R., Kotoky, J., & Devi, R. (2016). Antidiabetic and Antilipidemic Effect of Musa balbisiana Root Extract: A Potent Agent for Glucose Homeostasis in Streptozotocin-Induced Diabetic Rat. Frontiers in pharmacology, 7102. https://doi.org/10.3389/fphar.2016.00102
Kalita, Himadri, et al. "Antidiabetic and Antilipidemic Effect of Musa balbisiana Root Extract: A Potent Agent for Glucose Homeostasis in Streptozotocin-Induced Diabetic Rat." Frontiers in pharmacology vol. 7 (2016): 102. doi: https://doi.org/10.3389/fphar.2016.00102
Kalita H, Boruah DC, Deori M, Hazarika A, Sarma R, Kumari S, Kandimalla R, Kotoky J, Devi R. Antidiabetic and Antilipidemic Effect of Musa balbisiana Root Extract: A Potent Agent for Glucose Homeostasis in Streptozotocin-Induced Diabetic Rat. Front Pharmacol. 2016 May 02;7:102. doi: 10.3389/fphar.2016.00102. eCollection 2016. PMID: 27199747; PMCID: PMC4852310.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2016 May 02;7:102. doi: 10.3389/fphar.2016.00102. eCollection 2016.

Antidiabetic and Antilipidemic Effect of Musa balbisiana Root Extract: A Potent Agent for Glucose Homeostasis in Streptozotocin-Induced Diabetic Rat.

Frontiers in pharmacology

Himadri Kalita, Dulal C Boruah, Meetali Deori, Ankita Hazarika, Rahul Sarma, Sima Kumari, Raghuram Kandimalla, Jibon Kotoky, Rajlakshmi Devi

Affiliations

  1. Biochemistry Laboratory, Life Sciences Division, Institute of Advanced Study in Science and Technology Guwahati, India.
  2. Department of Botany, Goalpara College Goalpara, India.
  3. Drug Discovery Laboratory, Institute of Advanced Study in Science and Technology Guwahati, India.

PMID: 27199747 PMCID: PMC4852310 DOI: 10.3389/fphar.2016.00102

Abstract

Folklore studies have revealed that Musa balbisiana Colla (MB; Family: Musaceae) has high medicinal properties. The purpose of the present study is to evaluate antihyperglycemic, and antioxidant activity of MB extracts in streptozotocin (STZ) induced diabetic rats. In vitro antioxidant and antidiabetic activity of MB extracts, i.e., root extract (RE), shoot extract and inflorescence extract were determined by using various methods viz 1,-1-diphenyl-2-picrylhydrazyl (DPPH) and a method to assess their possible effect on glucose diffusion across gastrointestinal tract and identify bioactive compound of potent extract. In vivo antilipidemic and antidiabetic activity was evaluated by administrating oral dose of RE for 15 days on STZ- induced diabetic rat. RE showed highest antioxidant activity by scavenging DPPH radical (IC50 32.96 μg/ml) and inhibit 30% glucose movement in vitro. The methanol extract of root showed the presence of calyx [4] arene category of the compound. Furthermore, RE treated rat revealed a reduction in fasting blood glucose (62.5%), serum total cholesterol (36.2%), triglyceride (54.5%), and low-density lipoprotein (50.94%) after 15 days as compared to STZ treated animal. There was an initiation of regenerative structures of the affected organs after 15 days of RE treatment. Histopathological observations clearly differentiate the structural changes in pancreas, liver, and kidney of STZ and RE treated group. The presence of calyx [4] arene class of compound may be responsible for its antioxidant and antidiabetic properties by absorbing glucose in vivo.

Keywords: antioxidant; crude fiber; free radical; hyperglycemia; hyperlipidemia

References

  1. Luminescence. 1999 May-Jun;14(3):169-74 - PubMed
  2. Cardiovasc Res. 2000 Aug 18;47(3):446-56 - PubMed
  3. J Am Soc Nephrol. 2001 Jun;12(6):1211-7 - PubMed
  4. JAMA. 2002 Jan 16;287(3):360-72 - PubMed
  5. Free Radic Res. 2002 Feb;36(2):177-87 - PubMed
  6. J Agric Food Chem. 2002 Aug 28;50(18):5236-40 - PubMed
  7. Methods Find Exp Clin Pharmacol. 2003 Jul-Aug;25(6):453-6 - PubMed
  8. Arch Biochem Biophys. 1959 May;82(1):70-7 - PubMed
  9. Ann N Y Acad Sci. 2003 Nov;1005:43-54 - PubMed
  10. Nutrition. 2004 Mar;20(3):280-5 - PubMed
  11. Endocr Rev. 2005 May;26(3):380-92 - PubMed
  12. Pharmacol Res. 2005 Oct;52(4):313-20 - PubMed
  13. Life Sci. 2006 Jun 13;79(3):306-10 - PubMed
  14. Singapore Med J. 2006 Aug;47(8):670-5 - PubMed
  15. J Cardiovasc Pharmacol. 1990;16 Suppl 9:S1-7 - PubMed
  16. Lasers Med Sci. 2009 Sep;24(5):761-8 - PubMed
  17. Pancreas. 2009 Apr;38(3):e80-6 - PubMed
  18. Diabetes Res Clin Pract. 2010 Mar;87(3):302-12 - PubMed
  19. Clin Chim Acta. 1991 Feb 15;196(2-3):143-51 - PubMed
  20. Lancet. 2010 Jun 26;375(9733):2254-66 - PubMed
  21. J Food Sci. 2011 Jan-Feb;76(1):H7-H10 - PubMed
  22. Evid Based Complement Alternat Med. 2011;2011:852720 - PubMed
  23. J Org Chem. 2011 Dec 16;76(24):10039-49 - PubMed
  24. Diabetologia. 1990 Aug;33(8):462-4 - PubMed
  25. J Ethnopharmacol. 2012 Feb 15;139(3):801-6 - PubMed
  26. Saudi Pharm J. 2010 Jul;18(3):173-8 - PubMed
  27. J Ethnopharmacol. 2014 Apr 28;153(2):326-37 - PubMed
  28. Carcinogenesis. 1989 Jun;10(6):1003-8 - PubMed
  29. Nutrition. 2016 Oct;32(10):1081-91 - PubMed
  30. Eur J Clin Nutr. 1988 Apr;42(4):307-12 - PubMed
  31. Am J Clin Nutr. 1987 Jul;46(1):72-7 - PubMed
  32. Anal Biochem. 1979 Jun;95(2):351-8 - PubMed
  33. Eur J Biochem. 1974 Sep 16;47(3):469-74 - PubMed
  34. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
  35. J Ethnopharmacol. 1983 Mar;7(2):205-34 - PubMed
  36. Anal Biochem. 1982 Oct;126(1):131-8 - PubMed
  37. J Ethnopharmacol. 1994 Jul 22;43(3):167-71 - PubMed
  38. J Pharm Pharmacol. 1997 Jan;49(1):105-7 - PubMed

Publication Types